Carolyn Michelle Cohen

Title: Carolyn Cohen: Innovator in Pharmaceutical Synthesis

Introduction

Carolyn Cohen is a notable inventor based in Somerville, MA (US). She has made significant contributions to the field of pharmaceutical synthesis, particularly with her work on apremilast. Her innovative approach has led to advancements in the synthesis processes of this important compound.

Latest Patents

Cohen holds a patent for a process for synthesizing apremilast. The patent details a method that involves reacting 3-acetamidophthalic anhydride with (S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethan-1-amine or a salt thereof to produce apremilast. Additionally, the patent outlines processes for isolating apremilast from the reaction mixture, showcasing her expertise in chemical synthesis.

Career Highlights

Cohen is currently employed at Amgen Inc., a leading biotechnology company. Her work at Amgen has allowed her to focus on innovative solutions in drug development and synthesis. With her extensive knowledge and experience, she has become a valuable asset to her team.

Collaborations

Cohen has collaborated with notable colleagues, including Matthew G Beaver and Neil Fred Langille. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Carolyn Cohen's contributions to the field of pharmaceutical synthesis, particularly through her patent on apremilast, highlight her role as an influential inventor. Her work continues to impact the industry positively, and her collaborations further enhance the potential for future innovations.